AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NeuroSense Therapeutics Ltd.

$1.99 -$13.61 (-87.24%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$2.13
Day Range
$1.99$2.22
Year Range
$1.99$25.40
Market Cap
3.77M
AVG Volume
21.01K
Trailing/Forward PE
-0.28/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · Q
-6M-4M-2M02M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
NRSN Net Income (USD) by quarter
PeriodNet Income (USD)
25 Q4-3.21M
25 Q3-3.21M
25 Q2-2.35M
25 Q1-2.35M
24 Q4-1.8M
24 Q3-2.15M
24 Q2-857K
24 Q1-5.4M
23 Q4-2.95M
23 Q3784K
Operating Income (USD) · Q
-4M-3M-2M-1M023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
NRSN Operating Income (USD) by quarter
PeriodOperating Income (USD)
25 Q4-3.2M
25 Q3-3.2M
25 Q2-2.35M
25 Q1-2.35M
24 Q4-1.77M
24 Q3-2.11M
24 Q2-3.03M
24 Q1-2.99M
23 Q4-3.29M
23 Q3-2.9M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NRSN

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

NeuroSense Therapeutics Ltd.
NRSN
Stockpicker

Video analysis: NRSN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NRSN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.